Clinical Trial Update: Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in Allergic Conjunctivitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of an anti-allergy drug delivered via a contact lens for allergic conjunctivitis completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• Anti-Allergy Drug With a Contact Lens

Snippet

Sponsor: Vistakon Pharmaceuticals | Conditions: Allergic Conjunctivitis | Phase 3 | Status: COMPLETED